TABLE 1.

Strains used in this study, ordered numerically

StrainYr (country) of isolationaClinical origin(s)bVirulence-associated determinant(s)cmecA (MRSA)dspa type
8325t211
00-010042000SSS (h) eta, etbt159
00-014372000 (Bulgaria)SSS (h) eta t159
00-014882000Pyodermia (c) eta, etbt269
00-018762000SSS (h) eta, etbt284
02-015672002Septicemia (h)+t045
02-024042002Furuncle (c) lukS-lukF +t044
02-024242002Colonization+t002
02-025122002VAP (h)+t001
02-027122002VAP+t026
02-027502002Furuncle (c) lukS-lukF t284
02-027562002Wound infection (h)+t038
02-028112002Wound infection (h)+t038
02-028782002Furuncle (c) lukS-lukF t159
02-031792002Septicemia (h)+t001
02-035342002Wound infection (h)+t001
02-039252002Furuncle (c) lukS-lukF +t044
03-002202003Urinary tract infection (h)+t005
03-003972003Nasal colonization (h)+t032
03-012282003Nasal colonization (h)+t022
03-012652003Nasal swab tst +t021
03-014782003Surgical wound infection (h)+t032
03-014862003TSS tst t271
03-016212003TSS tst t021
03-016792003TSS tst t012
03-018162003Furuncle (c) lukS-lukF +t019
03-019002003Wound infection (h)+t018
03-021062003 (Israel)(h)+t002
03-021212003 (Israel)(h)+t002
03-022802003Wound infection (h)+t008
03-022862003Wound infection (h)+t008
03-023092003Pyodermia (h)+t008
03-024442003VAP (h)+t032
03-024942003Cystic fibrosis tst +t268
03-025752003Surgical wound infection (veth)+t036
03-027732003Furuncle (c) lukS-lukF +t175
04-006082004 (United Kingdom)Skin infection (c) lukS-lukF +t310
04-018722004(c) lukS-lukF +t019
04-020802004Wound infection (h)+t037
04-029362004Abscess (c) lukS-lukF +t002
04-029812004VAP (h)+t003
05-000432005VAP (h)+t003
05-010422005Nasal colonization (h)+t030
05-010892005Furunculosis (c) lukS-lukF +t310
05-01197-12005Abscess (c) lukS-lukF +t008
05-018252005Abscess, skin (c) lukS-lukF +t008
05-018512005Vaginal swab+t004
05-019772005Wound infection (h)+t001
05-020102005Perineal swab (h)+t003
05-020402005Furunculosis (c) lukS-lukF +t008
05-020652005Furuncle (c) lukS-lukF t1151
05-02086-22005Furuncle (c) lukS-lukF t017
05-020912005Abscess (c) lukS-lukF t318
05-021272005Wound infection (h)+t001
05-021392005Wound infection+t004
05-022122005Urinary tract infection (h)+t003
05-023182005Furuncle (c) lukS-lukF t435
81-014081981Mastitis puerperalis (h) lukS-lukF t021
87-010541987Mastitis puerperalis (h) lukS-lukF t021
93-001341993Wound infection (h)+t051
93-006351993Shunt infection, dialysis (h)+t037
93-009941993VAP (h)+t139
93-010001993Septicemia (h)+t009
93-011501993Wound infection (h)+t004
94-014501994Pneumonia (h)+t051
95-005431995Tropical pyomyositits (c) tst +t021
95-5441995 (Uganda)Tropical pyomyositis (c) lukS-lukF t159
96-008421996Septicemia (h)+t004
96-016781998Bacteremia (h)+t032
96-320101996 (United Kingdom)HARMONY (h) tst +t018
97-008251997Furuncle (c) lukS-lukF +t044
97-014511997 (Uganda)Tropical pyomyositis (c) lukS-lukF t308
97-019661997Surgical wound infection (h)+t009
97-02594-11997VAP (h)+t001
97S1011997 (Belgium)HARMONY (h)+t045
98-001311998VAP (h)+t001
98-004061998Septicemia (h)+t051
98-01155-21998Wound infection (h)+t001
98-014421998Abscess (h)+t009
98-016181998SSS (c) eta t159
98-019071998VAP (h) tst +t018
98-019761998Osteomyelitis (h) tst +t018
98-020881998Nasal colonization+t004
99-006531998Wound infection (h)+t001
99-1591999 (United Kingdom)HARMONY (h)+t018
C2SAU00102002Wound infectiont216
C2SAU00322002Nasal colonization tst t276
C2SAU00772002Nasal colonizationt275
M1SAU00392005Nasal colonization tst t138
M3SAU00122002Nasal colonization tst t012
MSAU1922002Nasal colonizationt274
NCTC119391985 (United Kingdom)Nosocomial environment+t037
Pl251999 (Poland)HARMONY (h)+t001
PS801955Mastitis puerperalis (h) lukS-lukF t021
PS951972 (United States)Reference strain for phage 95t065
sau2742004VAP (h)t586
sau2852004Nasal colonization (h)t242
Slovenia 141999 (Slovenia)HARMONY (h)+t001
Slovenia 301999 (Slovenia)HARMONY (h)+t178
  • a Isolated in Germany, unless otherwise noted.

  • b VAP, ventilator-associated pneumonia; TSS, toxic shock syndrome; SSS staphylococcal scaled skin syndrome; (h), hospital acquired; (c), community acquired; (veth), veterinary hospital acquired.

  • c As determined by PCR.

  • d +, presence; −, absence.